Area of research
Cellular and Molecular Neuroscience · Pharmacology
Research interest
Research interests include Treatment of Major Depression, Tryptophan and brain disorders, Neuroscience and Neuropharmacology Research, and Neurotransmitter Receptor Influence on Behavior.
Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor
Mechanisms of ketamine and its metabolites as antidepressants
Antidepressant-relevant concentrations of the ketamine metabolite (2 <i>R</i> ,6 <i>R</i> )-hydroxynorketamine do not block NMDA receptor function
Alpha2B-Adrenergic Receptor Overexpression in the Brain Potentiate Air Pollution-induced Behavior and Blood Pressure Changes
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Mechanisms of ketamine action as an antidepressant
Synthesis and <i>N</i>-Methyl-<scp>d</scp>-aspartate (NMDA) Receptor Activity of Ketamine Metabolites
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Molecular actions and clinical pharmacogenetics of lithium therapy
Antenatal prediction of postpartum depression with blood DNA methylation biomarkers